Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.60 |
| ▸ | HRH1 | P35367 | 4/20 | 0.54 |
| ▸ | HTR2A | P28223 | 3/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3593094 | 0.98 | MAOA (0.58) | MAOAHRH1HTR2ASIGMAR1 | |
| SCHEMBL27478848 | 0.98 | MAOA (0.58) | MAOAHRH1HTR2ASIGMAR1 | |
| SCHEMBL309769 | 0.93 | MAOA (0.50) | MAOAHRH1HTR2ASIGMAR1CYP2A6 | |
| SCHEMBL11803736 | 0.87 | MAOA (0.40) | MAOAHRH1HTR2ASIGMAR1MAOB | |
| SCHEMBL11690401 | 0.85 | SIGMAR1 (0.41) | MAOAHRH1HTR2ASIGMAR1MAOB | |
| SCHEMBL758587 | 0.82 | — | — | |
| SCHEMBL3680378 | 0.82 | MAOA (0.75) | MAOAHRH1HTR2ACYP2A6TAAR1 | |
| SCHEMBL3034286 | 0.81 | MAOA (0.38) | MAOAHRH1HTR2ASIGMAR1MAOB | |
| SCHEMBL28209200 | 0.80 | TAAR1 (0.52) | HTR2ACYP2A6SMN1; SMN2TAAR1LOXL2 | |
| SCHEMBL9350714 | 0.79 | MAOA (0.71) | MAOAHRH1HTR2AMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114350024-B | Compound containing phosphorus and sulfonate as well as preparation method and application thereof | 福建新安科技有限责任公司 | 2023-06-23 | — | — | CN | claimed |
| CN-114262440-B | Phosphorus-containing, silicon-containing and sulfonate-containing compound, and preparation method and application thereof | 福建新安科技有限责任公司 | 2022-12-09 | — | — | CN | claimed |
| CN-114196022-B | Phosphorus-containing, silicon-containing and sulfonate-containing compound, and preparation method and application thereof | 福建新安科技有限责任公司 | 2022-11-29 | — | — | CN | claimed |
| CN-114350024-A | Phosphorus-containing and sulfonate-containing compound, and preparation method and application thereof | 福建新安科技有限责任公司 | 2022-04-15 | — | — | CN | claimed |
| CN-114292299-A | Phosphorus-containing, nitrogen-containing and sulfonate-containing compound, and preparation method and application thereof | 福建新安科技有限责任公司 | 2022-04-08 | — | — | CN | claimed |
| CN-114262347-A | Phosphorus-containing, nitrogen-containing and sulfonate-containing compound, and preparation method and application thereof | 福建新安科技有限责任公司 | 2022-04-01 | — | — | CN | claimed |
| CN-114262440-A | Phosphorus-containing, silicon-containing and sulfonate-containing compound, and preparation method and application thereof | 福建新安科技有限责任公司 | 2022-04-01 | — | — | CN | claimed |
| CN-114195824-A | Phosphorus-containing, nitrogen-containing and sulfonate-containing compound, and preparation method and application thereof | 福建新安科技有限责任公司 | 2022-03-18 | — | — | CN | claimed |
| CN-114196022-A | Phosphorus-containing, silicon-containing and sulfonate-containing compound, and preparation method and application thereof | 福建新安科技有限责任公司 | 2022-03-18 | — | — | CN | claimed |
| CN-114350024-B | Compound containing phosphorus and sulfonate as well as preparation method and application thereof | 福建新安科技有限责任公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-114262440-B | Phosphorus-containing, silicon-containing and sulfonate-containing compound, and preparation method and application thereof | 福建新安科技有限责任公司 | 2022-12-09 | — | — | CN | disclosed |
| CN-114196022-B | Phosphorus-containing, silicon-containing and sulfonate-containing compound, and preparation method and application thereof | 福建新安科技有限责任公司 | 2022-11-29 | — | — | CN | disclosed |
| CN-114350024-A | Phosphorus-containing and sulfonate-containing compound, and preparation method and application thereof | 福建新安科技有限责任公司 | 2022-04-15 | — | — | CN | disclosed |
| CN-114292299-A | Phosphorus-containing, nitrogen-containing and sulfonate-containing compound, and preparation method and application thereof | 福建新安科技有限责任公司 | 2022-04-08 | — | — | CN | disclosed |
| EP-1645576-A1 | PROPYLENE BLOCK COPOLYMER | Mitsubishi Chemical Corporation (JP) | 2006-04-12 | — | — | EP | disclosed |
| US-20060019822-A1 | Palladium catalyst composition | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2006-01-26 | — | — | US | disclosed |
| CN-1681592-A | Palladium catalyst composition | WAKO PURE CHEMICAL INDUSTIES L (JP) | 2005-10-12 | — | — | CN | disclosed |
| EP-1537913-A1 | PALLADIUM CATALYST COMPOSITION | Wako Pure Chemical Industies, Ltd. (JP) | 2005-06-08 | — | — | EP | disclosed |
| WO-2005049607-A1 | TRIAZINE DIMERS FOR THE TREATMENT OF AUTOIMMUNE DISEASES | PROMETIC BIOSCIENCES INC. (CA) | 2005-06-02 | — | — | WO | disclosed |
| CN-1192015-C | Cell adhesion inhibitors | BIOGEN INC (US) | 2005-03-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060019822-A1 | Palladium catalyst composition | ODC1, NUDC, ADH1C | MAOA 1512/4885HRH1 2656/4885HTR2A 4855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.